The Valley Desk

NCT00524303 · Interventional trial

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Overall registry status Completed

Phase 2

Conditions Neoplasms, Breast

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov